日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes

一种针对SARS-CoV-2的中和抗体,具有广泛的刺突蛋白结合覆盖范围,并经过修饰以实现最佳治疗效果。

Yu Guo # ,Lisu Huang # ,Guangshun Zhang # ,Yanfeng Yao # ,He Zhou # ,Shu Shen # ,Bingqing Shen ,Bo Li ,Xin Li ,Qian Zhang ,Mingjie Chen ,Da Chen ,Jia Wu ,Dan Fu ,Xinxin Zeng ,Mingfang Feng ,Chunjiang Pi ,Yuan Wang ,Xingdong Zhou ,Minmin Lu ,Yarong Li ,Yaohui Fang ,Yun-Yueh Lu ,Xue Hu ,Shanshan Wang ,Wanju Zhang ,Ge Gao ,Francisco Adrian ,Qisheng Wang ,Feng Yu ,Yun Peng ,Alexander G Gabibov ,Juan Min ,Yuhui Wang ,Heyu Huang ,Alexey Stepanov ,Wei Zhang ,Yan Cai ,Junwei Liu ,Zhiming Yuan ,Chen Zhang ,Zhiyong Lou ,Fei Deng ,Hongkai Zhang ,Chao Shan ,Liang Schweizer ,Kun Sun ,Zihe Rao

Postharvest Treatments with Three Yeast Strains and Their Combinations to Control Botrytis cinerea of Snap Beans

使用三种酵母菌株及其组合进行采后处理以控制菜豆灰霉病

Mingfang Feng, You Lv, Tiantian Li, Xinmao Li, Jiayin Liu, Xiuling Chen, Yao Zhang, Xu Chen, Aoxue Wang

A randomized, double-blind, placebo-controlled study of B-cell lymphoma 2 homology 3 mimetic gossypol combined with docetaxel and cisplatin for advanced non-small cell lung cancer with high expression of apurinic/apyrimidinic endonuclease 1

一项随机、双盲、安慰剂对照研究,评估B细胞淋巴瘤2同源性3模拟物棉酚联合多西他赛和顺铂治疗高表达脱嘌呤/脱嘧啶核酸内切酶1的晚期非小细胞肺癌的疗效。

Wang, Yuxiao; Li, Xuemei; Zhang, Liang; Li, Mengxia; Dai, Nan; Luo, Hao; Shan, Jinlu; Yang, Xueqin; Xu, Mingfang; Feng, Yan; Xu, Chengxiong; Qian, Chengyuan; Wang, Dong